{"title":"New product intros [amivantamab-vmjw, anifrolumab-fnia (first-in-class), asciminib, atogepant, avalglucosidase alfa-ngpt, bimekizumab, clascoterone, donafenib, lonapegsomatropin-tcgd, mobocertinib, samidorphan/olanzapine (new combination), teserpaturev, tisotumab vedotin (first-in-class), vosoritide","authors":"","doi":"10.1358/dot.2021.57.12.3388997","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicamentos de actualidad. Drugs of today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1358/dot.2021.57.12.3388997","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
